nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease
|
De Carli, Fabrizio |
|
2018 |
46 |
2 |
p. 334-347 |
artikel |
2 |
Amyloid burden identifies neuropsychological phenotypes at increased risk of progression to Alzheimer’s disease in mild cognitive impairment patients
|
Ciarmiello, Andrea |
|
2018 |
46 |
2 |
p. 288-296 |
artikel |
3 |
Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [18F]FDG PET
|
Hellwig, Sabine |
|
2018 |
46 |
2 |
p. 312-323 |
artikel |
4 |
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes
|
Pietroboni, Anna M. |
|
2018 |
46 |
2 |
p. 280-287 |
artikel |
5 |
A new frontier for amyloid PET imaging: multiple sclerosis
|
Morbelli, Silvia |
|
2018 |
46 |
2 |
p. 276-279 |
artikel |
6 |
Bertoldo, F., Boccardo, F., Bombardieri, E., Evangelista, L., Valdagni, R. (Eds.) Bone Metastases from Prostate Cancer: Biology, Diagnosis and Management
|
Mansi, Luigi |
|
2018 |
46 |
2 |
p. 535 |
artikel |
7 |
Correction to: Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer
|
Houdu, Benjamin |
|
2018 |
46 |
2 |
p. 533-534 |
artikel |
8 |
Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer
|
Moon, Seung Hwan |
|
2018 |
46 |
2 |
p. 446-454 |
artikel |
9 |
Differences in gray and white matter 18F-THK5351 uptake between behavioral-variant frontotemporal dementia and other dementias
|
Son, Hye Joo |
|
2018 |
46 |
2 |
p. 357-366 |
artikel |
10 |
Discovery of pre-therapy 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patients
|
Arshad, Mubarik A. |
|
2018 |
46 |
2 |
p. 455-466 |
artikel |
11 |
Dual-phase [18F]florbetapir in frontotemporal dementia
|
Asghar, Michael |
|
2018 |
46 |
2 |
p. 304-311 |
artikel |
12 |
Dynamic whole-body PET imaging: principles, potentials and applications
|
Rahmim, Arman |
|
2018 |
46 |
2 |
p. 501-518 |
artikel |
13 |
18F-FDG PET/CT diagnostic performance in solitary and multiple pulmonary nodules detected in patients with previous cancer history: reports of 182 nodules
|
Taralli, Silvia |
|
2018 |
46 |
2 |
p. 429-436 |
artikel |
14 |
First steps in an uncharted territory by WFNMB
|
Lee, Dong Soo |
|
2018 |
46 |
2 |
p. 524-530 |
artikel |
15 |
First steps in an uncharted territory by WFNMB
|
Lee, Dong Soo |
|
|
46 |
2 |
p. 524-530 |
artikel |
16 |
18F-labeled anti-human CD20 cys-diabody for same-day immunoPET in a model of aggressive B cell lymphoma in human CD20 transgenic mice
|
Zettlitz, Kirstin A. |
|
2018 |
46 |
2 |
p. 489-500 |
artikel |
17 |
Improved beta-amyloid PET reproducibility using two-phase acquisition and grey matter delineation
|
Belohlavek, Otakar |
|
2018 |
46 |
2 |
p. 297-303 |
artikel |
18 |
Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?
|
Ilyas, Hajira |
|
2018 |
46 |
2 |
p. 520-521 |
artikel |
19 |
Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer’s disease
|
Carter, Stephen F. |
|
2018 |
46 |
2 |
p. 348-356 |
artikel |
20 |
Metabotropic glutamate receptor subtype 5 is altered in LPS-induced murine neuroinflammation model and in the brains of AD and ALS patients
|
Müller Herde, Adrienne |
|
2018 |
46 |
2 |
p. 407-420 |
artikel |
21 |
Myocardial MIBG scintigraphy in genetic Parkinson’s disease as a model for Lewy body disorders
|
Gabilondo, Iñigo |
|
2018 |
46 |
2 |
p. 376-384 |
artikel |
22 |
Nicotinic receptor abnormalities as a biomarker in idiopathic generalized epilepsy
|
Garibotto, Valentina |
|
2018 |
46 |
2 |
p. 385-395 |
artikel |
23 |
Performance of 18F-FDG PET/MRI and 18F-FDG PET/CT for T and N staging in patients with non-small-cell lung cancer
|
Laffon, Eric |
|
2018 |
46 |
2 |
p. 522-523 |
artikel |
24 |
PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
|
Varnäs, Katarina |
|
2018 |
46 |
2 |
p. 367-375 |
artikel |
25 |
Prognostic analysis of interim 18F-FDG PET/CT in patients with diffuse large B cell lymphoma after one cycle versus two cycles of chemotherapy
|
Yuan, Ling |
|
2018 |
46 |
2 |
p. 478-488 |
artikel |
26 |
Prognostic impact of combining whole-body PET/CT and brain PET/MR in patients with lung adenocarcinoma and brain metastases
|
Ho, Kung-Chu |
|
2018 |
46 |
2 |
p. 467-477 |
artikel |
27 |
Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer
|
Kirchner, Julian |
|
2018 |
46 |
2 |
p. 437-445 |
artikel |
28 |
Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue
|
Koole, Michel |
|
2018 |
46 |
2 |
p. 396-406 |
artikel |
29 |
Severe posterior hypometabolism but normal perfusion in a patient with chronic fatigue syndrome/myalgic encephalomyelitis revealed by PET/MRI
|
Sahbai, S. |
|
2018 |
46 |
2 |
p. 531-532 |
artikel |
30 |
The good rays: let them shine!
|
Høilund-Carlsen, Poul F. |
|
2018 |
46 |
2 |
p. 271-275 |
artikel |
31 |
The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer’s disease
|
Jaillard, Alice |
|
2018 |
46 |
2 |
p. 324-333 |
artikel |
32 |
Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer
|
Houdu, Benjamin |
|
2018 |
46 |
2 |
p. 421-428 |
artikel |
33 |
Why should we be concerned about a “g”?
|
Frangos, Savvas |
|
2018 |
46 |
2 |
p. 519 |
artikel |